The Trump administration on Tuesday announced a deal giving Pfizer a three-year reprieve from planned tariffs, while the pharmaceutical giant committed to voluntarily lowering prices on unspecified drugs for US consumers.
President Donald Trump announced a landmark agreement with Pfizer to reduce prescription drug costs for Medicaid, promising similar deals with other drugmakers in the coming weeks.
The announcement comes just hours ahead of a potential government shutdown, amid partisan standoffs over healthcare and federal spending.
Pfizer to offer ‘Most-Favored-Nation’ pricing
Under the deal, Pfizer will provide Medicaid with most-favored-nation pricing, meaning the company will charge the lowest prices it offers in other developed countries. The agreement also ensures that this